ZnR/GPR39 regulates hepatic insulin signaling, tunes liver bioenergetics and ROS production, and mitigates liver fibrosis and injury
Open Access
- 18 October 2024
- journal article
- research article
- Published by Elsevier in Redox Biology
- Vol. 78, 103403
Abstract
No abstract availableKeywords
Funding Information
- Israel Science Foundation
This publication has 82 references indexed in Scilit:
- Preventing and Controlling Zinc Deficiency Across the Life Course: A Call to ActionAdvances in Nutrition, 2024
- Effects of Zinc Supplementation on Inflammatory Status and Nonalcoholic Steatohepatitis in Overweight or Obese Children: a Randomized Clinical TrialBiological Trace Element Research, 2023
- Insulin Regulation of Hepatic Lipid Homeostasis2023
- Effect of Zn Supplementation on Trace Element Status in Rats with Diet-Induced Non-alcoholic Fatty Liver DiseaseBiological Trace Element Research, 2019
- Pharmacological Inhibition of CCR2/5 Signaling Prevents and Reverses Alcohol‐Induced Liver Damage, Steatosis, and Inflammation in MiceHepatology, 2019
- The Zn 2+ -sensing receptor, ZnR/GPR39, upregulates colonocytic Cl − absorption, via basolateral KCC1, and reduces fluid lossBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2017
- Zinc and immunity: An essential interrelationArchives of Biochemistry and Biophysics, 2016
- GPR39: a Zn2+-activated G protein-coupled receptor that regulates pancreatic, gastrointestinal and neuronal functionsCellular and Molecular Life Sciences, 2010
- Zinc and the Liver: An Active InteractionDigestive Diseases and Sciences, 2007
- Protein Tyrosine Phosphatases as Targets of the Combined Insulinomimetic Effects of Zinc and OxidantsBioMetals, 2005